
MACK
Healthcare · Biotechnology · $223.7M market cap
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2018
EPS trend, 90 days to now · +100.0% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Mar 7, 2024 | After the close | — | -0.02 | — |
| Nov 2, 2023 | After the close | — | -0.02 | — |
| Aug 3, 2023 | After the close | — | -0.03 | — |
| May 4, 2023 | After the close | — | -0.02 | — |
| Mar 9, 2023 | After the close | — | -0.04 | — |
| Nov 3, 2022 | Before the open | — | -0.03 | — |
| Aug 4, 2022 | After the close | — | -0.04 | — |
| May 12, 2022 | Time not confirmed | — | -0.67 | — |
| Mar 9, 2022 | After the close | — | -0.67 | — |
| Nov 4, 2021 | Time not confirmed | — | -0.67 | — |
| Aug 5, 2021 | Time not confirmed | — | -0.67 | — |
| May 13, 2021 | Time not confirmed | — | -0.67 | — |
| Mar 11, 2021 | Time not confirmed | — | -0.67 | — |
| Nov 5, 2020 |
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company in the United States. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
| Time not confirmed |
| — |
| -0.08 |
| — |
| Aug 7, 2020 | Time not confirmed | — | -0.67 | — |
| May 7, 2020 | Time not confirmed | — | 0.02 | — |
| Feb 25, 2020 | Time not confirmed | -1.00 | -0.67 | +33.0% |
| Nov 11, 2019 | Time not confirmed | -0.83 | -0.67 | +19.3% |
| Aug 5, 2019 | Time not confirmed | -0.83 | -0.67 | +19.3% |
| May 10, 2019 | Time not confirmed | -0.92 | -0.78 | +15.2% |
| Mar 6, 2019 | Before the open | -0.83 | -0.67 | +19.3% |
| Nov 7, 2018 | Before the open | -0.27 | -0.92 | -240.7% |
| Aug 7, 2018 | Before the open | -1.28 | -1.33 | -3.9% |
| May 8, 2018 | Before the open | -1.15 | -1.33 | -15.7% |
| Mar 12, 2018 | Before the open | -0.28 | -1.08 | -285.7% |